Find case studies from across DigitalHealth.London’s network and programmes that are relevant to you.
Accelerator company Inhealthcare has developed a pioneering mobile health app to bring a new level of sophistication to the home monitoring of long-term conditions by…
The North West London Collaboration of Clinical Commissioning Groups is making incredible strides in implementing integrated care through the successful development and deployment of…
Congenica’s genome analysis software, Sapientia™, is having a very real impact on the lives of patients and their families. Here’s the Tolman’s story.
Puffin O’Hanlon and Michelle Eskinazi are involved in the ARIES study, which has developed smartphone app ‘My Journey 3’ to support recovery in psychosis. Here, they reveal more about this self-management tool and its potential impact for #tomorrowspatient
Digital programme Sleepio has been clinically proven to improve both sleep and mental health in the general population, in clinical settings, and in the workplace. How does this work, and what’s the potential impact on the UK’s healthcare system?
Tomorrow’s Patient blog: Pharmacist Murtada Alsaif describes how his frustration at being unable to communicate with his patients, led to him co-developing a software that translates the pharmacy dispensing label.
As part of our continuing Tomorrow’s Patient campaign, DigitalHealth.London profiles the medical research partnership between Moorfields Eye Hospital and Google DeepMind; potentially revolutionising the way professionals carry out eye tests and leading to earlier detection of common eye diseases.
DigitalHealth.London met with NHS intrapreneur Dr Nick Oliver to find out how he’s using digital technology to support people with type 1 diabetes to effectively self-manage their long term condition.
One of the start-ups selected for Velocity Health’s preventative digital healthcare accelerator programme, we look at the impact Pzizz could have for the two billion people globally suffering from insomnia.
We explore how aparito’s tech solution addresses the needs of its stakeholders simultaneously, thereby overcoming the economic challenges of bringing innovative and affordable medicines to patients with rare disease.
With atrial fibrillation (AF) and related illnesses affecting two million people in the UK and costing the NHS £2.2 billion each year, find out…